rs121908607
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The ENST00000450852.8(MOCS2):c.16C>T(p.Gln6Ter) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000322 in 1,552,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
ENST00000450852.8 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOCS2 | NM_176806.4 | c.16C>T | p.Gln6Ter | stop_gained, splice_region_variant | 1/7 | ENST00000450852.8 | NP_789776.1 | |
MOCS2 | NM_004531.5 | c.-633C>T | 5_prime_UTR_variant | 1/7 | ENST00000396954.8 | NP_004522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOCS2 | ENST00000450852.8 | c.16C>T | p.Gln6Ter | stop_gained, splice_region_variant | 1/7 | 1 | NM_176806.4 | ENSP00000411022 | ||
MOCS2 | ENST00000396954.8 | c.-633C>T | 5_prime_UTR_variant | 1/7 | 1 | NM_004531.5 | ENSP00000380157 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000259 AC: 4AN: 154276Hom.: 0 AF XY: 0.0000365 AC XY: 3AN XY: 82268
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1400304Hom.: 0 Cov.: 33 AF XY: 0.00000145 AC XY: 1AN XY: 690916
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change creates a premature translational stop signal (p.Gln6*) in the MOCS2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MOCS2A are known to be pathogenic (PMID: 21031595). This variant is present in population databases (rs121908607, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with molybdenum cofactor deficiency (PMID: 11746050). ClinVar contains an entry for this variant (Variation ID: 6113). For these reasons, this variant has been classified as Pathogenic. - |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A Pathogenic:1
Pathogenic, no assertion criteria provided | curation | SingHealth Duke-NUS Institute of Precision Medicine | Jun 07, 2017 | - - |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 22, 2001 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at